Jim Cramer Was Right About These 5 Stocks

4. Marathon Oil Corporation (NYSE:MRO)

Number of Hedge Fund Holders: 43

Percentage Increase in Share Price Over Past Month: 24.53%

Marathon Oil Corporation (NYSE:MRO) is an independent oil and gas exploration and production firm. The former Goldman Sachs employee was bullish on the energy industry during the Lightning Round segment of his show on May 18, giving Marathon a Buy recommendation as well. 

On April 21, Truist analyst Neal Dingmann maintained a Buy rating on Marathon Oil Corporation (NYSE:MRO) stock and raised the price target to $41 from $34, urging oil and gas firms to focus on efficiencies and costs in order to take advantage of continued strong commodity prices. 

Among the hedge funds being tracked by Insider Monkey, New York-based investment firm DE Shaw is a leading shareholder in Marathon Oil Corporation (NYSE:MRO) with 4.5 million shares worth more than $113 million. 

In its Q4 2021 investor letter, Harding Loevner highlighted a few stocks and Edwards Lifesciences Corporation (NYSE:EW) was one of them. Here is what the fund said:

“Innovation can foster growth in Health Care fields other than drug discovery. Edwards Lifesciences Corporation (NYSE:EW) makes minimally invasive devices to treat heart disease or for critical care monitoring. Its transcatheter heart valve, SAPIEN, is the most-implanted aortic heart valve in the world. Having settled a lawsuit with Abbott over alleged patent infringement, Edwards Lifesciences Corporation (NYSE:EW) is now moving ahead with a newer product line called PASCAL to treat elderly or frail patients—for whom currently available treatments are ineffective—for mitral and tricuspid disease. PASCAL is the fruit of the company’s ongoing investment in research and development. Between PASCAL and its next-generation SAPIEN valve, the company expects to double its addressable market to approximately US$20 billion by 2028.”